HPB Parallel Session 1

Thursday, March 10, 2022

3:00 PM – 4:30 PM CST

Location:Chantilly East

Moderator(s)

E. Ramsay Camp, MD, MSCR

Chief, Division of Surgical Oncology Olga Keith Wiess Chair of Surgery Michael E. DeBakey Department of Surgery
Baylor College of Medicine
Houston, TX, United States
Annabelle Fonseca, MD, MHS

Assistant Professor
University of South Alabama

Participants should be aware of the following financial/non-financial relationships:

E. Ramsay Camp, MD, MSCR: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Annabelle L. Fonseca, MD, MHS: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentations:

3:01 PM – 3:09 PM CST

38: Multidimensional Immunophenotyping of Intraductal Papillary Mucinous Neoplasms Reveals Novel T Cell and Macrophage Signature
Abstract Presenter: Austin M. Eckhoff, MD – Duke University
3:09 PM – 3:11 PM CST

38: Q&A
Abstract Presenter: Austin M. Eckhoff, MD – Duke University
3:11 PM – 3:19 PM CST

31: Combination Therapy with PXS-5505 Reduces Myeloid Suppression and Improves Overall Survival in Murine Cholangiocarcinoma
Abstract Presenter: Paul R. Burchard, MD – University of Rochester Medical Center
3:19 PM – 3:21 PM CST

31: Q&A
Abstract Presenter: Paul R. Burchard, MD – University of Rochester Medical Center
3:21 PM – 3:29 PM CST

42: Recurrence-free Survival versus Overall Survival as a Primary End Point for Resectable Colorectal Liver Metastasis Studies: Analysis of 2,983 Curative-intent Hepatectomies
Abstract Presenter: Brett Ecker, MD – MSKCC
3:29 PM – 3:31 PM CST

42: Q&A
Abstract Presenter: Brett Ecker, MD – MSKCC
3:31 PM – 3:39 PM CST

37: Modulating the Gut Microbiome Stimulates Anti-tumor Immunity in Cigarette Smoking-driven Cancer Progression
Abstract Presenter: vikas Dudeja, MD, FACS – University of Alabama
3:39 PM – 3:41 PM CST

37: Q&A
Abstract Presenter: vikas Dudeja, MD, FACS – University of Alabama
3:41 PM – 3:49 PM CST

40: Preoperative Exercise Attenuates the Progression of Liver Metastases After Surgical Stress by Altering the Immune Environment
Abstract Presenter: Amblessed Onuma, MD MS – The Ohio State University Wexner Medical Center
3:49 PM – 3:51 PM CST

40: Q&A
Abstract Presenter: Amblessed Onuma, MD MS – The Ohio State University Wexner Medical Center
3:51 PM – 3:59 PM CST

41: Radiographic, Biochemical, or Pathologic Response to Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: Which Is Best?
Abstract Presenter: Chris Javadi, MD, PhD – Stanford
3:59 PM – 4:01 PM CST

41: Q&A
Abstract Presenter: Chris Javadi, MD, PhD – Stanford
4:01 PM – 4:09 PM CST

36: Mdsc-derived TNF Is a Novel Regulator of T-cell Dysfunction in Pancreatic Cancer
Abstract Presenter: Anna Bianchi, MS – University of Miami Miller School of Medicine, Department of Surgery
4:09 PM – 4:11 PM CST

36: Q&A
Abstract Presenter: Anna Bianchi, MS – University of Miami Miller School of Medicine, Department of Surgery
4:11 PM – 4:19 PM CST

45: Tumor Stroma Crosstalk in Pancreatic Ductal Adenocarcinoma Is Molecular Subtype Dependent
Abstract Presenter: Joseph Kearney, MD – University of North Carolina
4:19 PM – 4:21 PM CST

45: Q&A
Abstract Presenter: Joseph Kearney, MD – University of North Carolina
4:21 PM – 4:29 PM CST

32: Conditional Survival After Hepatectomy for Colorectal Liver Metastasis: Results from the Colorectal Liver Operative Metastasis International Collaborative
Abstract Presenter: Cristian D. Valenzuela, MD – Wake Forest Baptist Medical Center
4:29 PM – 4:30 PM CST

32: Q&A
Abstract Presenter: Cristian D. Valenzuela, MD – Wake Forest Baptist Medical Center